Multiple Sclerosis study: POWER-MS vs FLEX-MS
Official title Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
ClinicalTrials.gov ID: NCT05051618
What this study is testing
- What it's testing
- The study compares a strength‑based exercise program (POWER‑MS) with a stretching program (FLEX‑MS) to see if either reduces depression symptoms in people with multiple sclerosis.
- Who it's for
- Adults aged 18‑64 who have multiple sclerosis and a diagnosis of major depressive disorder.
- What's involved
- Participants will do either the POWER‑MS or FLEX‑MS exercise routine, attend scheduled sessions, and complete questionnaires and health tests during the study.
- Time commitment
- The trial lasts about 6 months, with regular exercise sessions and follow‑up visits to track depression and health changes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 64
You may be able to join if
- Physical confirmed diagnosis of Multiple Sclerosis (MS)
- Diagnosis of Major Depressive Disorder (MDD) - see below (MINI)
- English as primary language
- Eligible age (between 18 and 64 years old)
- Relapse and steroid free in past 30 days
You likely can't join if
- Godin Leisure Time Exercise Questionnaire (GLTEQ): Exclude if health contribution score of 14 units or more.
- Patient Determined Disease Steps (PDDS): Exclude if score above '2' (i.e., greater than mild ambulatory disability).
- Beck Depression Inventory-Fast Screen (BDI-FS): Exclude if a score less than '4'.
- Physical Activity Readiness Questionnaire (PAR-Q): Exclude if more than one yes/affirmative response on this 7-item self-report assessment.
- Telephone Interview for Cognitive Status (TICS-M): Exclude if scores less than 18.
- MINI International Neuropsychiatric Interview (version 7.0.2) based on the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V): Include...
See the full eligibility criteria
- Physical confirmed diagnosis of Multiple Sclerosis (MS)
- Diagnosis of Major Depressive Disorder (MDD) - see below (MINI)
- English as primary language
- Eligible age (between 18 and 64 years old)
- Relapse and steroid free in past 30 days
- Internet and email access
- Willingness to complete the testing and questionnaires, wear the accelerometer, undergo randomization, and engage in exercise testing
- Godin Leisure Time Exercise Questionnaire (GLTEQ): Exclude if health contribution score of 14 units or more.
- Patient Determined Disease Steps (PDDS): Exclude if score above '2' (i.e., greater than mild ambulatory disability).
- Beck Depression Inventory-Fast Screen (BDI-FS): Exclude if a score less than '4'. The scale measures depression and those with a score of '4' or below likely have very mild depression resulting in floor effects and/or...
- Physical Activity Readiness Questionnaire (PAR-Q): Exclude if more than one yes/affirmative response on this 7-item self-report assessment.
- Telephone Interview for Cognitive Status (TICS-M): Exclude if scores less than 18. This assessment is administered to ensure that all participants can adequately follow directions.
- MINI International Neuropsychiatric Interview (version 7.0.2) based on the Diagnostic and Statistical Manual of Mental Disorders V (DSM-V): Include those who meet the criteria for MDD, but exclude for other severe...
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.